DDS vs. NVO
Compare and contrast key facts about Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DDS or NVO.
Correlation
The correlation between DDS and NVO is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
DDS vs. NVO - Performance Comparison
Key characteristics
DDS:
-0.46
NVO:
-1.22
DDS:
-0.41
NVO:
-1.85
DDS:
0.95
NVO:
0.76
DDS:
-0.47
NVO:
-0.85
DDS:
-1.10
NVO:
-1.70
DDS:
18.01%
NVO:
29.80%
DDS:
43.14%
NVO:
41.57%
DDS:
-93.94%
NVO:
-71.29%
DDS:
-33.98%
NVO:
-56.90%
Fundamentals
DDS:
$5.17B
NVO:
$276.17B
DDS:
$36.82
NVO:
$3.43
DDS:
9.12
NVO:
18.10
DDS:
-1.28
NVO:
0.92
DDS:
0.78
NVO:
0.95
DDS:
2.93
NVO:
12.66
DDS:
$6.57B
NVO:
$225.05B
DDS:
$2.56B
NVO:
$190.45B
DDS:
$948.26M
NVO:
$113.24B
Returns By Period
In the year-to-date period, DDS achieves a -22.20% return, which is significantly higher than NVO's -26.67% return. Over the past 10 years, DDS has outperformed NVO with an annualized return of 12.68%, while NVO has yielded a comparatively lower 10.46% annualized return.
DDS
-22.20%
-6.39%
-6.18%
-20.68%
68.65%
12.68%
NVO
-26.67%
-8.97%
-44.36%
-50.09%
15.92%
10.46%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DDS vs. NVO — Risk-Adjusted Performance Rank
DDS
NVO
DDS vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DDS vs. NVO - Dividend Comparison
DDS's dividend yield for the trailing twelve months is around 7.75%, more than NVO's 2.60% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
DDS Dillard's, Inc. | 7.75% | 6.02% | 5.18% | 4.89% | 6.41% | 0.95% | 0.68% | 0.66% | 0.57% | 0.45% | 0.40% | 0.19% |
NVO Novo Nordisk A/S | 2.60% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
DDS vs. NVO - Drawdown Comparison
The maximum DDS drawdown since its inception was -93.94%, which is greater than NVO's maximum drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for DDS and NVO. For additional features, visit the drawdowns tool.
Volatility
DDS vs. NVO - Volatility Comparison
Dillard's, Inc. (DDS) has a higher volatility of 19.24% compared to Novo Nordisk A/S (NVO) at 16.79%. This indicates that DDS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DDS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Dillard's, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities